These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26874012)

  • 1. Enhancement of the safety of live influenza vaccine by attenuating mutations from cold-adapted hemagglutinin.
    Lee YJ; Jang YH; Kim P; Lee YH; Lee YJ; Byun YH; Lee KH; Kim K; Seong BL
    Virology; 2016 Apr; 491():1-9. PubMed ID: 26874012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H5N1 influenza A virus with K193E and G225E double mutations in haemagglutinin is attenuated and immunogenic in mice.
    Han PF; Li J; Hu Y; Sun W; Zhang S; Yang YH; Li YC; Kang XP; Wu XY; Zhu SY; Zhang Y; Zhu QY; Qin CF; Jiang T
    J Gen Virol; 2015 Sep; 96(9):2522-2530. PubMed ID: 25998916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
    Gambaryan AS; Lomakina NF; Boravleva EY; Kropotkina EA; Mashin VV; Krasilnikov IV; Klimov AI; Rudenko LG
    Influenza Other Respir Viruses; 2012 May; 6(3):188-95. PubMed ID: 21951678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
    Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
    Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
    Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
    Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the immunogenicity of adeno-vector vaccine against H5N1 influenza A virus].
    Zhang XG; Li KB; Ma J; Wang NF; Zhang XM; Sang YH; Dong J; Xu H; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):97-9. PubMed ID: 20104746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine.
    Lee YH; Jang YH; Seong BL
    Virology; 2017 Apr; 504():73-78. PubMed ID: 28157547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
    Min JY; Vogel L; Matsuoka Y; Lu B; Swayne D; Jin H; Kemble G; Subbarao K
    J Virol; 2010 Nov; 84(22):11950-60. PubMed ID: 20810733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
    Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus.
    Suguitan AL; Marino MP; Desai PD; Chen LM; Matsuoka Y; Donis RO; Jin H; Swayne DE; Kemble G; Subbarao K
    Virology; 2009 Dec; 395(2):280-8. PubMed ID: 19833372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemagglutinin protein of influenza A/Vietnam/1203/2004 (H5N1) contributes to hyperinduction of proinflammatory cytokines in human epithelial cells.
    Cheng X; Xu Q; Song E; Yang CF; Kemble G; Jin H
    Virology; 2010 Oct; 406(1):28-36. PubMed ID: 20667571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic and genetic analysis of H5 influenza viruses isolated from water birds for the purpose of vaccine use.
    Soda K; Ozaki H; Sakoda Y; Isoda N; Haraguchi Y; Sakabe S; Kuboki N; Kishida N; Takada A; Kida H
    Arch Virol; 2008; 153(11):2041-8. PubMed ID: 18932020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
    Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
    PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.